Pulmonary Aspergillosis in People with Cystic Fibrosis.

IF 2.3 3区 医学 Q2 CRITICAL CARE MEDICINE Seminars in respiratory and critical care medicine Pub Date : 2024-02-01 Epub Date: 2024-01-29 DOI:10.1055/s-0043-1777267
C Schwarz, P N Eschenhagen, J G Mainz, T Schmidergall, H Schuette, E Romanowska
{"title":"Pulmonary Aspergillosis in People with Cystic Fibrosis.","authors":"C Schwarz, P N Eschenhagen, J G Mainz, T Schmidergall, H Schuette, E Romanowska","doi":"10.1055/s-0043-1777267","DOIUrl":null,"url":null,"abstract":"<p><p>In the last decade, fungal respiratory diseases have been increasingly investigated for their impact on the clinical course of people with cystic fibrosis (CF), with a particular focus on infections caused by <i>Aspergillus</i> spp. The most common organisms from this genus detected from respiratory cultures are <i>Aspergillus fumigatus</i> and <i>Aspergillus terreus</i>, followed by <i>Aspergillus flavus</i>, <i>Aspergillus niger</i>, and <i>Aspergillus nidulans</i>. These species have been identified to be both chronic colonizers and sources of active infection and may negatively impact lung function in people with CF. This review article discusses definitions of aspergillosis, challenges in clinical practice, and current literature available for laboratory findings, clinical diagnosis, and treatment options for pulmonary diseases caused by <i>Aspergillus</i> spp. in people with CF.</p>","PeriodicalId":21727,"journal":{"name":"Seminars in respiratory and critical care medicine","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in respiratory and critical care medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/s-0043-1777267","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/29 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

In the last decade, fungal respiratory diseases have been increasingly investigated for their impact on the clinical course of people with cystic fibrosis (CF), with a particular focus on infections caused by Aspergillus spp. The most common organisms from this genus detected from respiratory cultures are Aspergillus fumigatus and Aspergillus terreus, followed by Aspergillus flavus, Aspergillus niger, and Aspergillus nidulans. These species have been identified to be both chronic colonizers and sources of active infection and may negatively impact lung function in people with CF. This review article discusses definitions of aspergillosis, challenges in clinical practice, and current literature available for laboratory findings, clinical diagnosis, and treatment options for pulmonary diseases caused by Aspergillus spp. in people with CF.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
囊性纤维化患者的肺曲霉菌病。
在过去十年中,真菌性呼吸道疾病对囊性纤维化(CF)患者临床病程影响的研究越来越多,尤其关注曲霉菌属(Aspergillus spp)引起的感染。 从呼吸道培养物中检测到的最常见曲霉菌属生物是烟曲霉(Aspergillus fumigatus)和赤曲霉(Aspergillus terreus),其次是黄曲霉(Aspergillus flavus)、黑曲霉(Aspergillus niger)和裸曲霉(Aspergillus nidulans)。这些菌种已被确认为慢性定植菌和活动性感染源,可能会对 CF 患者的肺功能产生负面影响。这篇综述文章讨论了曲霉菌病的定义、临床实践中面临的挑战,以及由曲霉菌属引起的 CF 患者肺部疾病的实验室结果、临床诊断和治疗方案的现有文献。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.10
自引率
0.00%
发文量
87
审稿时长
6-12 weeks
期刊介绍: The journal focuses on new diagnostic and therapeutic procedures, laboratory studies, genetic breakthroughs, pathology, clinical features and management as related to such areas as asthma and other lung diseases, critical care management, cystic fibrosis, lung and heart transplantation, pulmonary pathogens, and pleural disease as well as many other related disorders.The journal focuses on new diagnostic and therapeutic procedures, laboratory studies, genetic breakthroughs, pathology, clinical features and management as related to such areas as asthma and other lung diseases, critical care management, cystic fibrosis, lung and heart transplantation, pulmonary pathogens, and pleural disease as well as many other related disorders.
期刊最新文献
Future Considerations and Areas for Innovation for Pulmonary Rehabilitation in Chronic Obstructive Lung Disease Patients. Medications to Modify Aspiration Risk: Those That Add to Risk and Those That May Reduce Risk. The Role of Viral Infections in the Development and Progression of COPD. Therapy of Aspiration: Out-of-Hospital and In-Hospital-Acquired. Is There a Role for Bronchoscopy in Aspiration Pneumonia?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1